GBI Research Reports
GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.
Search GBI Research Reports
Latest Reports from GBI Research Reports
| |||||||||||||||||||||||
| Name | Date | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media | Jul 10, 2012 | ||||||||||||||||||||||
| ...Direct to Consumer (DTC) Advertising in Pharmaceuticals Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL... | |||||||||||||||||||||||
| Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise | Jul 10, 2012 | ||||||||||||||||||||||
| ...Multi-Targeted Therapies New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL #### Page #... | |||||||||||||||||||||||
| Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings | Jul 10, 2012 | ||||||||||||||||||||||
| ...Biobetters in Key Markets Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL #### Page... | |||||||||||||||||||||||
| Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development | Jul 10, 2012 | ||||||||||||||||||||||
| ...Protein and Peptide-based Therapeutics Trends in Drug Discovery and Development GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL #### Page # GBI Research Report Guidance · The second... | |||||||||||||||||||||||
| Biobanks - 2012 Year Book | Jul 10, 2012 | ||||||||||||||||||||||
| ...Biobanks - #### Year Book GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL #### Page # GBI Research Report Guidance GBI Research s report "Biobanks #### Yearbook" provides an... | |||||||||||||||||||||||
| Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth | Jul 10, 2012 | ||||||||||||||||||||||
| ...Biosimilars in Developed Countries Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published... | |||||||||||||||||||||||
| Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline | Jul 10, 2012 | ||||||||||||||||||||||
| ...Novel Therapies in Oncology Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL #### Page #... | |||||||||||||||||||||||
| Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities | Jul 10, 2012 | ||||||||||||||||||||||
| ...Pharmaceutical Pricing and Reimbursement in Oncology Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published... | |||||||||||||||||||||||
| Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity | Jul 10, 2012 | ||||||||||||||||||||||
| ...Active Pharmaceutical Ingredients (API) Market in Europe to #### Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity GBI Research Report Guidance © GBI Research. This is a licensed product and... | |||||||||||||||||||||||
| Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing | Jul 01, 2012 | ||||||||||||||||||||||
| ...Emerging Pharmaceutical Market in Brazil Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUL... | |||||||||||||||||||||||
| Wound Care Management Market to 2018 - Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries | Jun 30, 2012 | ||||||||||||||||||||||
| ...Wound Care Management Market to #### Advanced Wound Care Modalities and an Expanding Patient Base Create Significant Growth Opportunities in Emerging Countries GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIME####MR... | |||||||||||||||||||||||
| Polyurethane Global Market to 2016 - Growth of Rigid and Flexible Polyurethane Foams in Asia-Pacific to Drive Global Demand | Jun 30, 2012 | ||||||||||||||||||||||
| ...Polyurethane Global Market to #### Growth of Rigid and Flexible Polyurethane Foams in Asia-Pacific to Drive Global Demand GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBICH####MR / Published JUN ####... | |||||||||||||||||||||||
| Uranium Mining Market in North America to 2020 - Higher Production Driven by New Projects, Improved Mining Methods and Price Increases | Jun 25, 2012 | ||||||||||||||||||||||
| ...Uranium Mining Market in North America to #### Higher Production Driven by New Projects, Improved Mining Methods and Price Increases GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIMM####MR / Published JUN... | |||||||||||||||||||||||
| Uranium Mining Market in Asia-Pacific to 2020 - Availability of Large Uranium Reserves to Lay the Foundation for the Industry's Future Development | Jun 25, 2012 | ||||||||||||||||||||||
| ...Uranium Mining Market in Asia-Pacific to #### Availability of Large Uranium Reserves to Lay the Foundation for the Industry s Future Development GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied... | |||||||||||||||||||||||
| Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits | Jun 25, 2012 | ||||||||||||||||||||||
| ...Pharmaceutical Supply Chain in the US Advances in RFID and ePedigree Systems to Limit Drug Counterfeits GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUN #### Page # GBI... | |||||||||||||||||||||||
| Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production | Jun 25, 2012 | ||||||||||||||||||||||
| ...Biosimilars in Emerging Economies Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied... | |||||||||||||||||||||||
| Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth | Jun 25, 2012 | ||||||||||||||||||||||
| ...Generics in the Antivirals Market to #### Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir- HBV will Drive Volume Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be... | |||||||||||||||||||||||
| Emerging Pharmaceutical Market in Argentina - Domestic Pharmaceutical Companies Dominate the Market with More Than 55% of the Industry Revenue | Jun 25, 2012 | ||||||||||||||||||||||
| ...Emerging Pharmaceutical Market in Argentina Domestic Pharmaceutical Companies Dominate the Market with More Than ##% of the Industry Revenue GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUN ####... | |||||||||||||||||||||||
| Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards | Jun 25, 2012 | ||||||||||||||||||||||
| ...Gene Therapy Market to #### Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUN #### Page... | |||||||||||||||||||||||
| Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles | Jun 25, 2012 | ||||||||||||||||||||||
| ...Endpoints - Clinical Trials in Respiratory Diseases Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published JUN ####... | |||||||||||||||||||||||
